List of news
-
Category: UCLH news
Published on: 10 August 2022
The Bloomsbury Private Ward at the National Hospital for Neurology and Neurosurgery has now reopened following a major refurbishment and modernisation programme to create a warm and welcoming environment specifically designed for patients with neurological issues.
-
Category: UCLH news
Published on: 09 August 2022
UCLH is proud to reveal it has been shortlisted as Trust of the Year in this year’s Health Service Journal (HSJ) Awards. The HSJ Awards recognise outstanding contributions to healthcare.
-
Category: UCLH news
Published on: 15 June 2022
Our academic partner UCL has been ranked among the top 10 universities in the world according to the 2023 QS World University Rankings.
-
Category: Research news
Published on: 09 June 2022
A smartphone app that identifies severe neonatal jaundice could provide a cheaper alternative to expensive screening procedures, according to a study by UCLH, UCL and the University of Ghana.
-
Category: UCLH news
Published on: 13 May 2022
Five UCLH consultants have been elected Fellows of the Academy of Medical Sciences in recognition of their exceptional contributions to biomedical and health science and their ability to generate new knowledge and improve the health of people everywhere.
-
Category: Research news
Published on: 12 May 2022
UCL has been ranked number one in the UK in medicine, health and the life sciences for the quality of its research.
-
Category: Research news
Published on: 28 February 2022
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Category: Research news
Published on: 04 February 2022
The world’s first study to establish the best treatment options for adults struggling with severe hearing loss has launched at UCLH.
-
Category: Research news
Published on: 07 January 2022
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
Category: UCLH news
Published on: 06 January 2022
David Probert has been granted honorary professor status at UCL’s new Global Business School for Health (GBSH).
